Document Detail

Elevated VEGF-plasma levels in young patients with mild essential hypertension.
MedLine Citation:
PMID:  19067736     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Growing evidence shows that inflammation plays a pivotal role in the pathophysiology of essential hypertension (EH). Vascular endothelial cell growth factor (VEGF) is currently discussed as a possible mediator of inflammation. To investigate the hypothesis that VEGF plays a role as an inflammatory mediator in EH we performed the present pilot study of young patients in a very early stage of EH. MATERIALS AND METHODS: 15 young patients with mild EH [33.8 +/- 7.3 years, systolic blood pressure (SBP): 143.8 +/- 10.5 mmHg, diastolic blood pressure (DBP): 88.2 +/- 11.1 mmHg, mean arterial pressure (MAP) 106.6 +/- 10.4 mmHg] and 15 healthy controls (31.7 +/- 10.6 years) were examined. Blood was drawn from a peripheral vein and serum levels of VEGF, monocyte-chemoattractant-protein (MCP)-1, high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-6, and tumour-necrosis-factor (TNF)-alpha were measured via commercially available enzyme-linked immunoassays. RESULTS: Hypertensives showed increased plasma levels of VEGF (P < 0.05) and MCP-1 (P < 0.05). VEGF positively correlated with MAP (r = 0.46, P < 0.05) and MCP-1 (r = 0.63, P < 0.01). Multivariate analysis demonstrated VEGF to be an independent predictor of MCP-1 levels. Furthermore, hypertensives had higher levels of hsCRP (P < 0.01), IL-6 (P < 0.001) and TNF-alpha (P < 0.05). IL-6 levels correlated with SBP (r = 0.59, P < 0.001), DBP (r = 0.67, P < 0.001) and MAP (r = 0.46, P < 0.001). A significant positive correlation was also found between hsCRP levels and SBP (r = 0.39, P < 0.05). CONCLUSIONS: This pilot study demonstrates that in an early state of EH, inflammatory pathways have already been activated. Besides classical pro-inflammatory cytokines, VEGF serum levels are significantly elevated. The positive correlation of VEGF with MCP-1 is suggestive for the already described induction of MCP-1 via VEGF.
C Stumpf; J Jukic; A Yilmaz; D Raaz; R E Schmieder; W G Daniel; C D Garlichs
Related Documents :
3277736 - Mortality associated with diastolic hypertension and isolated systolic hypertension amo...
20535586 - Nicardipine infusion for blood pressure control in patients with subarachnoid hemorrhage.
11411736 - Arterial distensibility and ambulatory blood pressure monitoring in young patients with...
16107856 - High blood pressure is inversely related with the presence and extent of coronary colla...
1122936 - Enterohepatic haemodynamics in calves during acute systemic anaphylaxis.
7411126 - Human speech and blood pressure.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-12-01
Journal Detail:
Title:  European journal of clinical investigation     Volume:  39     ISSN:  1365-2362     ISO Abbreviation:  Eur. J. Clin. Invest.     Publication Date:  2009 Jan 
Date Detail:
Created Date:  2008-12-17     Completed Date:  2009-07-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0245331     Medline TA:  Eur J Clin Invest     Country:  England    
Other Details:
Languages:  eng     Pagination:  31-6     Citation Subset:  IM    
Department of Cardiology, University of Erlangen-Nuremberg, Erlangen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure / physiology*
Case-Control Studies
Hypertension / blood*,  physiopathology
Inflammation Mediators / blood,  metabolism*
Pilot Projects
Vascular Endothelial Growth Factor A / blood,  metabolism*
Young Adult
Reg. No./Substance:
0/Inflammation Mediators; 0/Vascular Endothelial Growth Factor A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in pat...
Next Document:  Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia ce...